Skip to main content
Signal8

Jaguar Health, Inc. (JAGX) Form S-3/A — Nov 3, 2026

$JAGXForm S-3/AFiled Nov 3, 2026, 2:55 PM ET0001193125-26-445132Original filing

Jaguar Health filed Amendment No. 1 to its Form S-3 shelf registration statement, registering up to $75,000,000 of common stock, preferred stock, warrants, subscription rights and units for sale from time to time. The amendment carries forward $41,376,058.50 of unsold securities from the company's prior effective S-3 (File No. 333-278861) under Rule 415(a)(6) and registers $33,623,941.50 of new capacity.

Key figures

Offering Price
0.8841
Total Shelf Capacity
75000000
Net fee due
15.93
Series r conversion ratio
1 preferred share to 5 common shares
Last reported sale price date
2026-11-02
Shares outstanding after series r conversion
13345986

AI analysis

Red flags5 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.